Allison has been working in clinical research since 1992 and managing clinical trials since 2001, working in the fields of hypertension, preeclampsia, HIV, obesity and respiratory medicine. Allison has worked in hospital settings (St George Hospital, Sydney; Leicester Royal Infirmary, UK; Groote Schuur Hospital, RSA) and University/Medical Research Institutes (Kirby and The George Institute).

Since working at The George Institute, she has worked as a Senior Project Manager and Operational Lead in APO and now holds an academic position in the Respiratory Programme. Allison has managed project teams to deliver multiple clinical trials and research projects such as TASCS, ECOS, PACE in COPD and now the BREATHE CDSS.

Alta Schutte is a SHARP Professor and Theme Lead for Cardiac, Vascular and Metabolic Medicine at UNSW Sydney; and Professorial Fellow at The George Institute Australia. She holds honorary appointments at the North-West University and University of the Witwatersrand in South Africa. She is the Past President of the International Society of Hypertension, Company Secretary of the Australian Cardiovascular Alliance, and Co-Chair of the Australian National Hypertension Taskforce.

Alta is a leading researcher with extensive experience in clinical trials and population-based studies in the field of blood pressure, hypertension and cardiovascular health. She has been the Chief Investigator of several multidisciplinary studies, published >450 papers in the field, and supervised over 85 postgraduate students. She is Chief Investigator of several Australian-funded trials and is a NHMRC Investigator Grant Leadership Fellow.

She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration, May Measurement Month global blood pressure screening campaign, World Health Organization working groups and the Lancet Commission of Hypertension. She is the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines. She is Associate Editor of the journal, Hypertension, and has received numerous international awards for her work, most recently the 2022 American Heart Association’s Harriet Dustan Award, and 2023 Peter Sleight Excellence Award in Hypertension Clinical Research from the World Hypertension League.

Dr Anna Campain is a biostatistician with experience in health, medical and bioinformatics research.

She has worked extensively with routinely-collected health data, both linked and non-linked. Anna has a special interest in using routinely-collected health datasets to explore and understand health patterns in high-risk or vulnerable populations to inform treatments, approaches and behaviours. She is passionate about research that will be translated to end-user benefit through changes in clinical guidelines, health policy and resource management.

Joining The George Institute for Global Health in 2018, Anna brings over a decade of experience in applied statistics. As an applied statistician, Anna is passionate about using robust, appropriate and contemporary statistical methods to investigate clinically important research questions. Her experience to date has involved the application of advanced regression methods and machine learning techniques to chronic disease research, the use of accessible data visualisation methods to disseminate findings to a wide research audience, and regional, state and national health program evaluation and impact investigations.

Kate has a background in Pharmacology and a PhD in the inflammatory system. She began her employment at TGI in March 2018, mainly working within the renal and metabolic division. Kate’s clinical research operations skills developed whilst working on the REDUCCTION study where she managed sites, coordinated event adjudication processes, maintained data trackers, monitored data collection, upheld ethics and research governance approvals, submitted ethics amendments, coordinated site payments, and maintained close communication with participating study sites. Her expertise has also been lent to other studies including TRIDENT (project forecasting and coordinating outcome adjudications), TRACK (unblinded team member), RESOLVE (event verification), and ATHENA (UAT). Experience has also been obtained in start-up, site initiation, site close-out, protocol and other document development, and exposure to data linkage processes.

Kate currently manages the PERFORM-AKI, ACCESS HD, DISCOVER and REVERSE studies.

Dr Katie Harris is a Senior Research Fellow in the Professorial Unit at the George Institute for Global Health. Her areas of expertise include Biostatistics and Clinical Epidemiology, awarded a PhD in Biostatistics from the University of Leeds, UK. She also holds a Conjoint Senior Lecturer position at the University of New South Wales, Sydney, Australia.

Katie has extensive experience working with big data, including population-based, linked and non-linked datasets, and clinical trials data. Her current research interests are in sex and gender differences, cardiovascular disease and hypertension, and dementia and cognitive decline.

Preety R. Rajbangshi is a Senior Research Fellow at The George Institute for Global Health, India, where she leads India's Global Women's Health Programme. She holds a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health, United States.

Her research focuses on women's health across the life course and strengthening health systems for primary care. With nearly two decades of experience as a researcher and practitioner, she has worked on maternal health, anaemia, and endometriosis. She has prior experience working with government health programmes at national and state levels in India.

Preety brings extensive field experience in community engagement with tribal communities, internally displaced populations, and women workers in tea plantations. Her work aims to address health inequities and generate practice-based evidence to inform action.

Yuan LI joined TGI China in January 2017. As the head of Nutrition and lifestyle program, Yuan’s research focused on nutrition and chronic disease prevention, currently working on projects such as Action on Salt China, EduSaltS,FoodSwitch and SmartDiet.

Yuan received PhD degree of nutrition and food hygiene from the National Institute for Nutrition and Health, China CDC in 2007 and acquired the associate professor qualification identified by the China’s Ministry of Health in 2011. Yuan was offered a conjoint lecturer in the Faculty of Medicine, University of New South Wales in 2017. Yuan is an accredited Registered Dietitian in China and a committee member of Nutrition and Non-communicable Disease Control Branch at Chinese Nutrition Society.

Yanqing graduated from Hebei Northern College in 2005 with majors in medical information management and information systems. After graduation she worked in various roles including Network and Data Manager, Call Center Manager, IT Engineer and Customer Relationship Manager. Previously she was the project assistnat to the China Rural Health Initiative (CHRI).

Norbert Berend is Head of Respiratory Research at the George Institute for Global Health and a member of the physiology group at the Woolcock Institute of Medical Research of which he was the Director from 2000 to 2012. He holds the academic title of Professor, Faculty of Medicine, UNSW Sydney; Professor Emeritus at the University of Sydney; and is a Visiting or Honorary Professor at three Chinese Universities.

He is a past President of the Thoracic Society of Australia and New Zealand and the Asian Pacific Society of Respirology. He has also held positions with the American Thoracic Society and European Respiratory Society. Norbert’s research interests include the pathophysiology of asthma and COPD and clinical intervention studies to improve the outcome of airways disease.

Norbert is a recipient of the TSANZ Medal, the APSR Medal and has received an Award of Merit from the European Respiratory Society. In 2003 Norbert was made a Member of the Order of Australia for services to respiratory medicine.

Christine Jenkins is Program Head, Respiratory at The George Institute for Global Health; Professor of Respiratory Medicine at UNSW Sydney and Clinical Professor in the Concord Clinical School, University of Sydney.

Christine has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease. Christine recently retired from clinical practice but continues to teach and supervise medical students and higher degree postgraduate students. She has had major roles in advocacy and leadership for lung health in Australia, most recently chairing Lung Foundation Australia, where she continues as a director, and previously chairing the National Asthma Campaign and the Federal Government’s National Asthma Advisory Group. She has participated in many government advisory groups and guidelines and implementation initiatives to enhance resources, skills, capacity and clinical outcomes in airways disease.

Christine’s area of research interest is the clinical management of airways disease and patient-reported outcomes in response to therapeutic interventions, and she is currently implementing trials in asthma and COPD management and pulmonary rehabilitation in Australia and Asia. Her current work has also examined the role of telemedicine in specialist care during the pandemic and she is overseeing an ambitious study to develop a digital application for primary care to improve the diagnosis and evidence-based management of breathlessness.

In 2002 Christine was made a Member of the Order of Australia in recognition of services to respiratory medicine as a physician, administrator and educator, especially in the field of asthma education. In 2022, she was awarded the Governor General’s Medallion by His Excellency General the Honourable David Hurley AC DSC. This award recognises significant contributions to charities during the 2020 and 2021 pandemic years and is in recognition of Christine’s volunteer expertise, generosity, and exceptional leadership during the COVID-19 pandemic as Chair of Lung Foundation Australia.

Christine is a member and previous president of the Thoracic Society of Australia and New Zealand, and a member of the American Thoracic Society, European Respiratory Society and the Asia-Pacific Society of Respirology.

Ms. Rong LUO joined the George Institute for Global Health in January 2013 as research fellow. She is engaged in several research projects related to NCD, including stroke, mHealth systematic review and women health.

Ms. Rong LUO graduated from College of Public Health, Ningxia Medical University and got her master degree in 2007. From 2007 to 2012, she worked for the Office of Disease Control and Health Emergency Response and Office for China-US Collaboration Program on Emerging and Re-emerging Infectious Disease, Chinese Center for Disease Prevention and Control (China CDC). At China CDC, she worked as an project officer and participated in coordination for several major infectious disease epidemics control and health emergency (2008 Hand Foot Mouth Disease Epidemics Control/2008 Wenchuan Earthquake Health Emergency Response/2009 H1N1 Epidemics Control etc.), project management (including strategic plan and monitoring and evaluation), project implement (risk communication survey and study), capacity building and foreign affairs etc.

Dr Anna Palagyi is a health systems scientist with expertise in co-design methodology and implementation studies with mixed-methods evaluation. She holds positions as Program Lead - Ageing & Health Systems in the Centre for Health Systems Science at The George Institute for Global Health and Conjoint Associate Professor at UNSW Sydney.

Anna's research centres on the co-design of effective implementation strategies to strengthen primary health care services in resource-constrained settings of the Asia-Pacific region. She has a particular interest in the development of appropriate health system responses to population ageing: Anna previously implemented a national longitudinal study on aspects of healthy ageing in older Australians with cataract, and currently collaborates with governments, civil society organisations and academic institutions across several Pacific Island countries to identify national healthy ageing policy, program and service priorities.

Anna is committed to evidence-informed health policy and practice. She has a strong track record of partnering with government stakeholders in the design and implementation of policy-relevant research, has co-authored commissioned reports for government bodies and advocacy groups, and has produced policy briefs for government departments.